Cargando…

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know

IgA nephropathy (IgAN), the most common primary glomerular disease worldwide, is characterized by glomerular deposition of IgA1-containing immune complexes. The IgA1 hinge region (HR) has up to six clustered O-glycans consisting of Ser/Thr-linked N-acetylgalactosamine usually with β1,3-linked galact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohyama, Yukako, Renfrow, Matthew B., Novak, Jan, Takahashi, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396900/ https://www.ncbi.nlm.nih.gov/pubmed/34441764 http://dx.doi.org/10.3390/jcm10163467

Ejemplares similares

International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)

Commentary: When we don't know what we don't know
por: Paone, Gaetano
Publicado: (2020)

Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021)

From CERN to Entrepreneurship: we don't know what we don't know
por: Zucchelli, Piero
Publicado: (2017)

Zika: what we know and don't know
por: Diop, Doudou, et al.
Publicado: (2016)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Human Extraintestinal Sarcocystosis: What We Know, and What We don’t Know
por: Harris, V. C., et al.
Publicado: (2015)

COVID-19 in Children: What We Know and What We Don’t Know?
por: Jat, Kana Ram
Publicado: (2021)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

What We Know and Don't Know About Lyme Disease
por: Donta, Sam T.
Publicado: (2022)

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
por: Zelek, Wioleta M., et al.
Publicado: (2023)

The Etiology of Femoroacetabular Impingement: What We Know and What We Don’t
por: Chaudhry, Harman, et al.
Publicado: (2014)

The Novel Coronavirus Outbreak: What We Know and What We Don’t
Publicado: (2020)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Investigating emotions in Parkinson's disease: what we know and what we still don't know
por: Sotgiu, Igor, et al.
Publicado: (2013)

ECLS-associated infections in adults: what we know and what we don’t yet know
por: Abrams, Darryl, et al.
Publicado: (2019)

Crescent IgA Nephropathy and its association with anti-neutrophil cytoplasm antibody: what do we know?
por: Zamoner, Welder, et al.
Publicado: (2022)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
por: Tanaka, Mototsugu, et al.
Publicado: (2011)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review
por: Sun, Qiang, et al.
Publicado: (2016)

Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management
por: Shafiei, Mostafa, et al.
Publicado: (2012)

Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know
por: Kerensky, Todd, et al.
Publicado: (2017)

Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know
por: Terhorst-Molawi, Dorothea, et al.
Publicado: (2023)

Immune responses to Tilapia lake virus infection: what we know and what we don’t know
por: Kembou-Ringert, Japhette E., et al.
Publicado: (2023)

Asthma-COPD Overlap Syndrome: What We Know and What We Don't
por: Sin, Don D.
Publicado: (2017)

Digital Hazards for Feeding and Eating: What We Know and What We Don't
por: Ioannidis, Konstantinos, et al.
Publicado: (2021)

Neurocognitive functioning in bipolar disorder: What we know and what we don’t
por: Keramatian, Kamyar, et al.
Publicado: (2022)

What we still don't know about AIDS
por: Robertson, Miranda
Publicado: (2009)

Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2016)

Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
por: Ohyama, Yukako, et al.
Publicado: (2022)

Neurologic Complications With Vaccines: What We Know, What We Don't, and What We Should Do
por: Nath, Avindra
Publicado: (2023)

Vasodilators in the treatment of acute heart failure: what we know, what we don’t
por: Metra, Marco, et al.
Publicado: (2008)

Acute Myocardial Response to Stretch: What We (don't) Know
por: Neves, João S., et al.
Publicado: (2016)

Low Carbohydrate and Low-Fat Diets: What We Don’t Know and Why We Should Know It
por: Seid, Heather, et al.
Publicado: (2019)

COVID-19 and the kidney: what we think we know so far and what we don’t
por: Farouk, Samira S., et al.
Publicado: (2020)

Soluble ST2 and Galectin-3: What We Know and Don’t Know Analytically
por: Mueller, Thomas, et al.
Publicado: (2016)

Managing the financial risks of climate change and pandemics: What we know (and don't know)
por: Ranger, Nicola, et al.
Publicado: (2021)

Online Porn Addiction: What We Know and What We Don’t—A Systematic Review
por: de Alarcón, Rubén, et al.
Publicado: (2019)

Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tvg1is9t4hkqi19rlc02ul7cad